Biotechnology Stocks I Performance Guide: Syndax Pharmaceuticals, Inc. (SNDX)
SNDX has no dividends.
Table and Chart of SNDX Performance
See what a $1,000 investment in SNDX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SNDX Returns | |
|---|---|
| Start Date | Apr-29-2016 |
| Start Price | $13.69 |
| End Date | Jul-26-2024 |
| End Price | $24.49 |
| # Prices | 100 |
| Min Date | Dec-31-2018 |
| Min Price | $4.45 |
| Max Date | Jan-31-2023 |
| Max Price | $28.70 |
| Total Return | 78.89% |
| Annualized Return | 7.23% |
| Current Value of $1,000 Purchase | $1,789 |
| Number Returns | 4,950 |
| Average Return | 64.47% |
| Number Profitable Returns | 3,662 |
| Percent Profitable Returns | 73.98% |
| Number Unprofitable Returns | 1,288 |
| Percent Unprofitable Returns | 26.02% |
| Profitable to Unprofitable Returns Ratio | 2.84 |
| SNDX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,097,482,000 |
| Beta | 0.939 | Price to Sales | 12.67 |
| Earnings per Share | $-3.2400 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 3.334 |
| PRICE DATA | |
| 52 Week High | $25.34 |
| 52 Week Low | $11.21 |
| Analyst Target Price | $34.73 |
| 50-Day Moving Average | $21.01 |
| 200-Day Moving Average | $19.97 |
| FINANCIAL DATA | |
| Revenue per Share | $2.173 |
| Revenue | $126,576,000 |
| Profit Margin | 0% |
| Return on Equity | -51.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SNDX Compare Returns with S&P 500
SNDX Trendline Chart
SNDX Moving Average Chart
SNDX Stock Return Map - See Patterns of Gains and Losses
SNDX Stock Returns/Purchase Dates